The Outcomes of Living Donor Robotic Assisted Kidney Transplantation
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorWest China Hospital
About this trial
The technology for robot-assisted kidney transplantation (RAKT) has become increasingly advanced, with numerous studies demonstrating comparable outcomes between RAKT surgery and open surgery. This advancement is particularly noteworthy as it extends its suitability to transplant patients with obesity. It will be important to explore the results of robot-assisted kidney transplantation as compared with open surgery or within cohorts.
Eligibility criteria
Qualifiers
living-donor kidney transplant recipients
receiving standard triad immunosuppressive regimen
Disqualifiers
active infection
multi-organ transplantation
malignancy history in the donor and recipient
human immunodeficiency virus infection
Trial design
Treatments tested in this trial
- Not listed
Trial groups
400 Participants
are grouped into 2 trial groupsLocations
1West China Hospital, Sichuan University610041, ChengduSichuan, China
Sponsors and collaborators
West China Hospital
Lead sponsor
Source ClinicalTrials.gov